Malicious content in issues or pull requests can trick AI agents in CI/CD workflows into running privileged commands in an ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
SAN FRANCISCO and SUZHOU, China, Nov. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
IBI3011 is an innovative humanized monoclonal antibody blocking IL1α, IL1β, IL36 simultaneously, by targeting the extracellular domain of IL1RAP. It profoundly inhibits the activation of IL1α, IL1β, ...
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to ...
East Hanover, October 25, 2025 – Novartis announced today plans to present data from 27 company- or investigator-sponsored abstracts across its Immunology portfolio and pipeline at the 2025 American ...
Adobe (NASDAQ:ADBE) and GitLab (NASDAQ:GTLB) shares slipped in early trading on Tuesday as investment firm Mizuho said the market believes it is seeing a “severe negative impact” from artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback